Enrique Bernal

2.1k total citations
48 papers, 1.0k citations indexed

About

Enrique Bernal is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Enrique Bernal has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 14 papers in Infectious Diseases and 14 papers in Epidemiology. Recurrent topics in Enrique Bernal's work include HIV Research and Treatment (12 papers), HIV-related health complications and treatments (11 papers) and Cardiac Arrhythmias and Treatments (9 papers). Enrique Bernal is often cited by papers focused on HIV Research and Treatment (12 papers), HIV-related health complications and treatments (11 papers) and Cardiac Arrhythmias and Treatments (9 papers). Enrique Bernal collaborates with scholars based in Spain, Bulgaria and United States. Enrique Bernal's co-authors include Irene Marín, Antonio Hernández‐Madrid, Concepción Moro, José M. González Rebollo, J.M. Galván Cano, Gonzalo Peña, Pedro Cabeza, Aníbal Rodríguez, Lucas Cano and Manuel Gómez‐Bueno and has published in prestigious journals such as Circulation, Antimicrobial Agents and Chemotherapy and Nutrients.

In The Last Decade

Enrique Bernal

42 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Enrique Bernal Spain	13	691	149	95	85	84	48	1.0k
Gianluca Savarese Italy	10	427 0.6×	28 0.2×	73 0.8×	103 1.2×	79 0.9×	20	604
Claire Gozalo France	12	89 0.1×	60 0.4×	43 0.5×	72 0.8×	24 0.3×	34	491
Robert B. Dorman United States	17	75 0.1×	71 0.5×	82 0.9×	79 0.9×	126 1.5×	25	810
Manuela Lucchiari Italy	13	80 0.1×	53 0.4×	229 2.4×	183 2.2×	23 0.3×	20	656
Vladimír Šrámek Czechia	14	176 0.3×	40 0.3×	121 1.3×	34 0.4×	65 0.8×	70	588
Kurt Quitzau Switzerland	8	309 0.4×	22 0.1×	39 0.4×	34 0.4×	29 0.3×	11	459
Kimberly Wong United States	12	65 0.1×	78 0.5×	183 1.9×	128 1.5×	165 2.0×	17	695
David Hoelscher United States	9	80 0.1×	141 0.9×	43 0.5×	27 0.3×	12 0.1×	13	354
Donogh Maguire United Kingdom	12	62 0.1×	81 0.5×	34 0.4×	33 0.4×	15 0.2×	25	426

Countries citing papers authored by Enrique Bernal

Since Specialization

Citations

This map shows the geographic impact of Enrique Bernal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique Bernal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique Bernal more than expected).

Fields of papers citing papers by Enrique Bernal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrique Bernal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique Bernal. The network helps show where Enrique Bernal may publish in the future.

Co-authorship network of co-authors of Enrique Bernal

This figure shows the co-authorship network connecting the top 25 collaborators of Enrique Bernal. A scholar is included among the top collaborators of Enrique Bernal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrique Bernal. Enrique Bernal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pons-Fuster, Eduardo, María José Alcaraz García, Marta Moreno, et al.. (2025). HLA-A*03 may confer protection against long COVID through an enhanced immune response. Infectious Diseases Now. 55(4). 105057–105057.

Moreno, Cristina, Rebeca Izquierdo, Belén Alejos, et al.. (2024). Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain. AIDS Patient Care and STDs. 38(7). 305–314. 4 indexed citations

Santos, José Ramón, Peré Domingo, Joaquín Portilla, et al.. (2023). A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes. Open Forum Infectious Diseases. 10(11). ofad542–ofad542. 2 indexed citations

Blanco, José Ramón, Francisco Arnaíz de las Revillas, Enrique Bernal, et al.. (2021). Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clinical Microbiology and Infection. 27(6). 892–896. 76 indexed citations

Jiménez‐Sousa, María Ángeles, Javier López Jiménez, Amanda Fernández‐Rodríguez, et al.. (2019). VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naïve HIV-Infected Patients. Journal of Clinical Medicine. 8(3). 311–311. 8 indexed citations

García, María José Alcaraz, et al.. (2019). Prognostic value of pro-adrenomedullin and NT-proBNP in patients referred from the emergency department with influenza syndrome.. PubMed. 31(3). 180–184. 6 indexed citations

Medrano, Luz María, Mónica Gutiérrez‐Rivas, Julià Blanco, et al.. (2018). Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy. Journal of Translational Medicine. 16(1). 343–343. 6 indexed citations

Bernal, Enrique, et al.. (2017). Nomograma para predecir mal pronóstico en pacientes procedentes de urgencias con sepsis y bajo riesgo de daño orgánico evaluado mediante SOFA. Emergencias. 29(2). 81–86. 5 indexed citations

Rosado‐Sánchez, Isaac, Inmaculada Jarrín, Ana Isabel Álvarez‐Ríos, et al.. (2017). Higher levels of IL-6, CD4 turnover and Treg frequency are already present before cART in HIV-infected subjects with later low CD4 recovery. Antiviral Research. 142. 76–82. 20 indexed citations

10.

Bernal, Enrique, et al.. (2017). The N-terminal pro brain natriuretic peptide is the best predictor of mortality during hospitalization in patients with low risk of sepsis-related organ failure. Medicina Clínica (English Edition). 149(5). 189–195. 3 indexed citations

11.

Bernal, Enrique, Ángeles Muñoz, Irene Marín, et al.. (2016). The CD4/CD8 Ratio is Inversely Associated with Carotid Intima-Media Thickness Progression in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Treatment. AIDS Research and Human Retroviruses. 32(7). 648–653. 26 indexed citations

12.

García, Féderico, Eva Poveda, Maria Jesús Pérez‐Elías, et al.. (2014). Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48‐week analysis of the PROTEST study. Journal of the International AIDS Society. 17(4S3). 19520–19520. 1 indexed citations

13.

Bernal, Enrique, et al.. (2014). The CD4:CD8 ratio is associated with IMT progression in HIV‐infected patients on antiretroviral treatment. Journal of the International AIDS Society. 17(4S3). 19723–19723. 9 indexed citations

14.

Portilla, Joaquín, Piedad Arazo, Laura Pérez‐Martínez, et al.. (2014). Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV‐patients. The BITER Study. Journal of the International AIDS Society. 17(4S3). 19803–19803. 6 indexed citations

15.

Bernal, Enrique, et al.. (2014). Improvement of endothelial function after switching previously treated HIV‐infected patients to an NRTI‐sparing bitherapy with maraviroc. Journal of the International AIDS Society. 17(4S3). 19726–19726. 6 indexed citations

16.

Guzmán, María G., Javier López Jiménez, María Ángeles Jiménez‐Sousa, et al.. (2013). ACSM4 Polymorphisms Are Associated With Rapid AIDS Progression in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(1). 27–32. 7 indexed citations

17.

Bernal, Enrique, et al.. (2006). Patrón alveolar nodular como forma de presentación de la toxicidad pulmonar por amiodarona. Radiología. 48(2). 99–102. 1 indexed citations

18.

Hernández‐Madrid, Antonio, et al.. (2005). Resincronización cardíaca. Impacto socioeconómico sanitario. Mortalidad del procedimiento. Relación coste-beneficio. Impacto en la clase funcional/calidad de vida. Pronóstico y seguimiento Cardiac resynchronization. Socioeconomic and health care impact. Mortality of procedure. Cost-benefit ratio. Impact on functional class/quality of life. Prognosis and follow-up. 1 indexed citations

19.

Hernández‐Madrid, Antonio, Carlos Escobar, José M. González Rebollo, et al.. (2003). Angiotensin Receptor Blocker as Adjunctive Therapy for Rhythm Control in Atrial Fibrillation: Results of the Irbesartan-Amiodarone Trial. Cardiac Electrophysiology Review. 7(3). 243–246. 20 indexed citations

20.

Cabeza, Pedro, Antonio Hernández‐Madrid, José M. González Rebollo, et al.. (2003). Lesiones producidas por la ablación con radiofrecuencia del istmo cavotricuspídeo en un modelo experimental. Revista Española de Cardiología. 56(10). 963–970.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact